News for Diurnal Group plc (4UU.F)

Published at

Feb 2, 2021 8:10 AM

by marketscreener.com

positive

positive

Diurnal : Chronocort Phase 3 and Safety Extension Study results published in JCEM

Posted on Tuesday, 02/Feb/2021 Posted by michelle Peer-reviewed data from largest ever completed interventional clinical trial in CAH Authors conclude that Chronocort?... | February 2, 2021

DNL.L 4UU.F

Read more →
Published at

Jan 14, 2021 2:00 PM

by benzinga.com

positive

positive

Eton Pharmaceuticals Announces Acquisition of Canadian Rights for ALKINDI® SPRINKLE

DEER PARK, Ill., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (NASDAQ:ETON), a specialty pharmaceutical company focused on developing and ...

ETON DNL.L 4UU.F

Read more →
Published at

Jan 13, 2021 11:16 AM

by marketscreener.com

mixed

mixed

Diurnal : signs agreement with Er-Kim for the distribution of Alkindi and Chronocort in Turkey

Posted on Wednesday, 13/Jan/2021 Posted by michelle Diurnal Group plc , the specialty pharmaceutical company targeting patient needs in chronic endocrine diseases, announces a... | January 13, 2021

DNL.L 4UU.F ETON

Read more →